Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Chinese Journal of Diabetes ; (12): 989-992, 2017.
Article Dans Chinois | WPRIM | ID: wpr-703378

Résumé

Objective To investigate the association between serum chemotactic factor fractalkine (FKN) level and obesity and type 2 diabetic mellitus (T2DM).Methods According to BMI,88 cases of healthy persons with normal glucose tolerance (NGT) were divided into normal weight group (A group,n =44,BMI< 24 kg/m2) and obesity group (B group,n =44,BMI≥ 24 kg/m2);88 cases of newly diagnosed T2DM patients (T2DM group) were divided into the normal weight group (C group,n=44,BMI<24 kg/m2) and obesity group (D group,n=44,BMI≥24 kg/m2).FKN and TNF-α levels were measured by ELISA.Results Serum FKN in T2DM group (0.625± 0.090) ng/ml was higher than that in NGT group (0.395±0.110) ng/ml (P<0.01).The levels of FKN in C group (0.55±0.08) ng/ml were higher than that of A group (0.34±0.14) ng/ml and B group (0.45±0.08) ng/ml P<0.01).Serum FKN was positively correlated with and the levels of FPG,HbA1 c,WHR,BMI,C reactive protein (C-RP),HOMA-IR and TNF-α (r=0.578,0.592,0.616,0.596,0.909,0.872 and 0.827,P<0.01) in T2DM group.FKN was negatively correlated with HDL-C (r =-0.216,P < 0.05).Multivariate regression analysis showed that C-RP,BMI and TNF-α were independent factors related to FKN (β=0.441,0.158 and 0.221,P<0.05).Conclusion Serum FKN is closely related to inflammation response in T2DM patients.FKN may play an important role in the pathogenesis and development of T2DM and obesity.

SÉLECTION CITATIONS
Détails de la recherche